The impact of EGFR mutation on definitive concurrent chemoradiation therapy for inoperable stage III lung adenocarcinoma.
Kosuke Tanaka
No relevant relationships to disclose
Tomoyo Oguri
No relevant relationships to disclose
Tatsuya Yoshida
No relevant relationships to disclose
Jangchul Park
No relevant relationships to disclose
Junichi Shimizu
No relevant relationships to disclose
Yoshitsugu Horio
No relevant relationships to disclose
Takeshi Kodaira
No relevant relationships to disclose
Toyoaki Hida
No relevant relationships to disclose